Reengineering an Antiarrhythmic Drug Using Patient hiPSC Cardiomyocytes to Improve Therapeutic Potential and Reduce Toxicity
収録刊行物
-
- Cell Stem Cell
-
Cell Stem Cell 27 (5), 813-821.e6, 2020-11
Elsevier BV